DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRD) VS LENALIDOMIDE AND DEXAMETHASONE (RD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): EFFICACY AND SAFETY UPDATE (POLLUX)
Bahlis, N.J., Moreau, P., Nahi, H., Plesner, T., Goldschmidt, H., Suzuki, K., Orlowski, R.Z., Rabin, N., Leiba, M., Oriol, A., Chari, A., San Miguel, J., Richardson, P.G., Usmani, S., O'Rourke, L., WuVolume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_153
Date:
June, 2017
File:
PDF, 68 KB
english, 2017
File converter
More search results
More benefits 
